UBS Group’s Doximity DOCS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-23,000
Closed -$801K 10450
2022
Q2
$801K Buy
23,000
+2,800
+14% +$110K ﹤0.01% 3902
2022
Q1
$1.05M Buy
+20,200
New +$1.02M ﹤0.01% 4048

Other funds holding DOCS

UBS Group's DOCS Position: Q1 2026 in Review

UBS Group reduced its Doximity (DOCS) stake by 3.8% in Q1 2026, selling an estimated $810K and leaving 654,262 shares worth $15.2M. The position accounts for ﹤0.01% of the portfolio, ranked #2882.

UBS Group first reported a position in DOCS in Q2 2021 and has held it in 20 quarters since. The position peaked at $63.1M in Q1 2025. 419 funds tracked by Wall St. Rank hold DOCS as of Q1 2026.

  • UBS Group held 654,262 shares of Doximity worth $15.2M as of Q1 2026.
  • UBS Group sold 25,998 Doximity shares in Q1 2026, an estimated $810K.
  • Doximity made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #2882 holding.
  • UBS Group first reported a position in Doximity in Q2 2021 and has held it in 20 quarters since.
  • UBS Group's Doximity position peaked at $63.1M in Q1 2025.
  • 419 funds tracked by Wall St. Rank held Doximity as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.